| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |